Center for Medicare Advocacy

Advancing Access to Medicare and Healthcare

Medicare Part D / Prescription Drugs

CMS Needs to Rein in Medicare Advantage Overpayments and Heighten Oversight of Insurance Industry

Center Comments Regarding CMS’ Advance Payment Notice and Proposed Part C & D Rule The Center for Medicare Advocacy recently submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding their Advance payment rule … [Read more...] about CMS Needs to Rein in Medicare Advantage Overpayments and Heighten Oversight of Insurance Industry

CMS Releases Proposed 2023 Rule for Medicare Advantage and Part D Plans

On January 6, 2022, CMS released CY 2023 Medicare Advantage and Part D Proposed Rule (CMS-4192-P) and an accompanying Press Release describing the overall rule, and a separate Press Release focusing on Part D prescription drug costs.  The … [Read more...] about CMS Releases Proposed 2023 Rule for Medicare Advantage and Part D Plans

Study Finds Cost-Sharing Increases Can be Deadly

A recent study supports the Center for Medicare Advocacy’s long-held concern about increasing out-of-pocket costs for Medicare beneficiaries. In summary, requiring beneficiaries to pay more of their own money will not make them savvier consumers; … [Read more...] about Study Finds Cost-Sharing Increases Can be Deadly

Final 2022 Rule for Medicare Parts C and D Released By Trump Administration

I. Overview On February 18, 2020, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule entitled “Medicare and Medicaid Programs; Contract Year 2021 and 2022 Policy and Technical Changes to the Medicare Advantage Program, … [Read more...] about Final 2022 Rule for Medicare Parts C and D Released By Trump Administration

Dismantling the Affordable Care Act Would Harm Medicare and Medicare Beneficiaries

Spotlight on Closing the Part D Coverage Gap (“Donut Hole”) The Supreme Court will review the constitutionality of the Affordable Care Act (ACA) this term in California v. Texas, with oral argument scheduled for November 10, 2020. This … [Read more...] about Dismantling the Affordable Care Act Would Harm Medicare and Medicare Beneficiaries

Senators Release Report Concerning Postal Service Problems and Delays in Receipt of Mail-Order Drugs

On September 9, 2020, U.S. Senators Bob Casey and Elizabeth Warren released a report entitled “Rapidly Increasing Postal Service Delivery Delays for Mail-Order.” The report focuses on recent operational changes made at the U.S. Postal Service (USPS) … [Read more...] about Senators Release Report Concerning Postal Service Problems and Delays in Receipt of Mail-Order Drugs

Center Letter Re: Impact of Postal Service Delays on Medicare Beneficiaries

September 3, 2020 VIA ELECTRONIC SUBMISSION The Honorable Robert P. Casey, Jr.United States Senate393 Russell Senate Office BuildingWashington, D.C. 20510 The Honorable Elizabeth WarrenUnited States Senate309 Hart Senate Office … [Read more...] about Center Letter Re: Impact of Postal Service Delays on Medicare Beneficiaries

Final Rule for Medicare Parts C and D Includes Weakened Standards for Medicare Advantage Networks

On May 22, 2020, the Centers for Medicare & Medicaid Services (CMS) published a final rule regarding Medicare Advantage (Medicare Part C) and Part D prescription drug plans (“C & D Rule”). The rule is entitled “Medicare Program; Contract Year … [Read more...] about Final Rule for Medicare Parts C and D Includes Weakened Standards for Medicare Advantage Networks

CMS Announces Voluntary Part D Program to Reduce Insulin Out-of-Pocket Costs for Some Enrollees

In a May 26, 2020 press release, the Centers for Medicare & Medicaid Services (CMS) “announced that over 1,750 standalone Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer … [Read more...] about CMS Announces Voluntary Part D Program to Reduce Insulin Out-of-Pocket Costs for Some Enrollees

Skip to content